A comparison of the effects of hexamethonium alone and in combination with 1-hydrazinophthalazine (apresoline) in the treatment of hypertension.
作者信息
ORGAIN E S, RAST C L, SIEBER H A
出版信息
Trans Am Clin Climatol Assoc. 1953;65:279-93.
Abstract
摘要
相似文献
1
A comparison of the effects of hexamethonium alone and in combination with 1-hydrazinophthalazine (apresoline) in the treatment of hypertension.
Trans Am Clin Climatol Assoc. 1953;65:279-93.
2
Results with oral hexamethonium alone and in combination with 1-hydrazinophthalazine (apresoline) in the therapy of hypertension.
Am J Med Sci. 1953 Apr;225(4):379-98. doi: 10.1097/00000441-195304000-00005.
3
The treatment of hypertension with hexamethonium and hydrazinophthalazine (apresoline).
Brooklyn Hosp J. 1953;11(3 3rd Quarter):125-34.
4
Hexamethonium and apresoline (1-hydrazinophthalazine).
Proc Staff Meet Mayo Clin. 1952 Nov 19;27(24):489-94.
5
Newer drugs in hypertension; combined effects of 1-hydrazinophthalazine (apresoline) and hexamethonium salts; a preliminary report.
Treat Serv Bull. 1953 Oct;8(9):573-8.
6
Treatment of hypertension with hexamethonium alone and in combination with apresoline.
Tex State J Med. 1953 Jul;49(7):516-22.
7
The treatment of severe arterial hypertension with hexamethonium and hydrazinophthalazine.
J Med Assoc Ga. 1953 Feb;42(2):78-81.
8
[The treatment of severe arterial hypertension with hexamethonium and hydrazinophthalazine].
Medizinische. 1952 Nov 29;20(48):1516-8.
9
Essential hypertension; treatment with hexamethonium and apresoline.
U S Armed Forces Med J. 1953 Jun;4(6):903-6.
10
A preliminary report on clinical experiences with hexamethonium and 1-hydrazinophthalazine in the treatment of diastolic hypertension.
J La State Med Soc. 1953 Apr;105(4):153-7.
本文引用的文献
1
Prognosis in essential hypertension; 8-year follow-up study of 430 patients on conventional medical treatment.
N Engl J Med. 1948 Dec 23;239(26):990-4. doi: 10.1056/NEJM194812232392602.
2
Renal hyperemia induced in man by a new phthalazine derivative.
Proc Soc Exp Biol Med. 1950 Jan;73(1):102. doi: 10.3181/00379727-73-17591.
3
Clinical evaluation of 1-hydrazinophthalazine (C-5968) in hypertension, with special reference to alternating treatment with hexamethonium.
Circulation. 1952 Jun;5(6):833-41. doi: 10.1161/01.cir.5.6.833.
4
Hexamethonium compounds in the treatment of hypertension.
Lancet. 1952 May 17;1(6716):993-6. doi: 10.1016/s0140-6736(52)90641-7.
5
Caution with regard to use of hexamethonium and "apresoline".
J Am Med Assoc. 1952 May 17;149(3):215-20. doi: 10.1001/jama.1952.02930200001001.
6
Control of hypertension by hexamethonium and 1-hydrazinophthalazine; preliminary observations.
AMA Arch Intern Med. 1952 Apr;89(4):523-40. doi: 10.1001/archinte.1952.00240040002001.
7
The effect of 1-hydrasinophthalasine in hypertension.
Circulation. 1952 Jan;5(1):28-37. doi: 10.1161/01.cir.5.1.28.
8
The treatment of hypertension with hexamethonium.
Circulation. 1952 Jan;5(1):20-7. doi: 10.1161/01.cir.5.1.20.
9
Treatment of hypertension by oral methonium compounds.
Br Med J. 1952 Feb 2;1(4752):251-4. doi: 10.1136/bmj.1.4752.251.
10
Treatment of arterial hypertension by penta- and hexamethonium salts; based on 150 tests on hypertensives of varied aetiology and 53 patients treated for periods of two to fourteen months.
Br Med J. 1951 Jun 2;1(4717):1217-28. doi: 10.1136/bmj.1.4717.1217.
Zotero 插件